Exactly one year ago, the first Pfizer coronavirus vaccine was administered in sub-Saharan Africa.

Since then, the vaccination program has lagged considerably.

The region only has enough vaccines to fully vaccinate one in eight people.

Follow this topic Follow

Receive notifications on important news about the coronavirus

In comparison, in the Netherlands there are more than nine vaccines available for every ten people, while in the Democratic Republic of Congo it is only one in a hundred.

Policy advisor Ben van Gils of Oxfam Novib warns that "with the new threat of the omikron variant, it is clear that we will not just leave the pandemic behind if a large part of the population of developing countries does not have access to affordable vaccines. If this does not change, we continue to deal with a wave of virus variants."

According to the People's Vaccine Alliance, a coalition of organizations and activists committed to a global vaccine that is freely available to everyone, the perfect breeding ground for new coronavirus variants such as omikron is being created.

That's because pharmaceutical companies refuse to openly share their vaccine knowledge and technology.

The reluctance of rich countries to guarantee access to affordable vaccines worldwide would also not help.

The Netherlands started large-scale donations to the COVAX vaccination aid program in October.

By the end of the year, the utility should have received 27 million corona vaccines from the Netherlands.

At the end of October, Oxfam Novib announced that rich countries and pharmaceutical companies are supplying poorer countries with far fewer corona vaccines than had been promised.

For example, the Netherlands would have supplied only 500,000 of the 27 million vaccines.